Advertisement
Table 2 Distribution of Pair-wise Interventions in meta-analyses in the CDSR
| Second Intervention | ||||||
|---|---|---|---|---|---|---|
| First Intervention | vs. Control | vs. Placebo | vs. Pharm | Vs. Non-Pharm1 from same category | vs. Non-Pharm1 from different category | Total |
| Pharmacological | 4027 (18%) | 4321 (19%) | 5571 (25%) | n/a | 186 (<1%) | 14105 (63%) |
| Vaccines | 95 (<1%) | 113 (<1%) | 0 (0%) | 49 (<1%) | 0 (0%) | 257 (1%) |
| Surgical | 241 (1%) | 2 (<1%) | 29 (<1%) | 1204 (5%) | 86 (<1%) | 1562 (7%) |
| Medical devices | 706 (3%) | 50 (<1%) | 82 (<1%) | 941 (4%) | 159 (<1%) | 1938 (9%) |
| Cellular and gene | 29 (<1%) | 6 (<1%) | 0 (0%) | 57 (<1%) | 7 (<1%) | 99 (<1%) |
| Radiotherapy | 124 (<1%) | 65 (<1%) | 3 (<1%) | 56 (<1%) | 63 (<1%) | 311 (1%) |
| Physical | 318 (1%) | 10 (<1%) | 8 (<1%) | 72 (<1%) | 39 (<1%) | 447 (2%) |
| Educational | 303 (1%) | 4 (<1%) | 1 (<1%) | 34 (<1%) | 27 (<1%) | 369 (2%) |
| Behavioural | 380 (2%) | 7 (<1%) | 3 (<1%) | 165 (<1%) | 14 (<1%) | 569 (3%) |
| Screening | 17 (<1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 17 (<1%) |
| Complementary | 216 (1%) | 104 (<1%) | 41 (<1%) | 8 (<1%) | 19 (<1%) | 388 (2%) |
| Psychological | 379 (2%) | 1 (<1%) | 6 (<1%) | 116 (<1%) | 44 (<1%) | 546 (2%) |
| Resources and infrastructure | 506 (2%) | 0 (0%) | 14 (<1%) | 52 (<1%) | 33 (<1%) | 605 (3%) |
| Complex | 505 (2%) | 36 (<1%) | 43 (<1%) | 200 (<1%) | 154 (<1%) | 938 (4%) |
| Other | 188 (1%) | 44 (<1%) | 8 (<1%) | 51 (<1%) | 11 (<1%) | 302 (1%) |
| Total | 8034 (36%) | 4763 (21%) | 5809 (26%) | 3005 (13%) | 842 (4%) | 22453 |
